Page 97 - Read Online

Wilson et al. Hepatoma Res 2020;6:57 I http://dx.doi.org/10.20517/2394-5079.2020.48 Page 11 of 11

line method: a large monocentric experience. J Gastrointest Liver Dis 2014;23:57-63.
19. Kong WT, Wang WP, Huang BJ, Ding H, Mao F. Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma
and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound. J Gastroenterol Hepatol 2014;29:576-80.
20. Murphy-Lavallee J, Jang HJ, Kim TK, Burns PN, Wilson SR. Are metastases really hypovascular in the arterial phase? The perspective
based on contrast-enhanced ultrasonography. J Ultrasound Med 2007;26:1545-56.
21. Albrecht T, Blomley MJ, Burns PN, Wilson S, Harvey CJ, et al. Improved detection of hepatic metastases with pulse-inversion US during
the liver-specific phase of SHU 508A: multicenter study. Radiology 2003;227:361-70.
22. Weskott HP. Detection and characterization of liver metastases. Radiologe 2011;51:469-74.
23. Laumonier H, Cailliez H, Balabaud C, Possenti L, Zucman-Rossi J, et al. Role of contrast-enhanced sonography in differentiation of
subtypes of hepatocellular adenoma: correlation with MRI findings. AJR Am J Roentgenol 2012;199:341-8.
24. Kim TK, Jang HJ, Burns PN, Murphy-Lavallee J, Wilson SR. Focal nodular hyperplasia and hepatic adenoma: differentiation with low-
mechanical-index contrast-enhanced sonography. AJR Am J Roentgenol 2008;190:58-66.
25. Dietrich CF, Mertens JC, Braden B, Schuessler G, Ott M, et al. Contrast-enhanced ultrasound of histologically proven liver hemangiomas.
Hepatology 2007;45:1139-45.
26. Durot I, Wilson SR, Willmann JK. Contrast-enhanced ultrasound of malignant liver lesions. Abdom Radiol (NY) 2018;43:819-47.
27. Lee HS, Kim MJ, An C. How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-
cholangiocarcinoma on gadoxetate-enhanced MRI? Eur Radiol 2019;29:2408-16.
28. Fowler KJ, Potretzke TA, Hope TA, Costa EA, Wilson SR. LI-RADS M (LR-M): definite or probable malignancy, not specific for
hepatocellular carcinoma. Abdom Radiol (NY) 2018;43:149-57.
29. Trillaud H, Bruel JM, Valette PJ, Vilgrain V, Schmutz G, et al. Characterization of focal liver lesions with SonoVue-enhanced sonography:
international multicenter-study in comparison to CT and MRI. World J Gastroenterol 2009;15:3748-56.
30. Seitz K, Bernatik T, Strobel D, Blank W, Friedrich-Rust M, et al. Contrast-enhanced ultrasound (CEUS) for the characterization of focal
liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients. Ultraschall Med
2010;31:492-9.
31. Guang Y, Xie L, Ding H, Cai A, Huang Y. Diagnosis value of focal liver lesions with SonoVue®-enhanced ultrasound compared with
contrast-enhanced computed tomography and contrast-enhanced MRI: a meta-analysis. J Cancer Res Clin Oncol 2011;137:1595-605.